InvestorsObserver
×
News Home

Do Analysts Expect Mesoblast limited (MESO) Stock to Rise?

Monday, September 28, 2020 10:26 AM | InvestorsObserver Analysts

Mentioned in this article

Do Analysts Expect Mesoblast limited (MESO) Stock to Rise?

Analysts who follow Mesoblast limited (MESO) on average expect it to decline -0.49% over the next twelve months. Those same analysts give the stock an average rating of Strong Buy.

That average rating earns Mesoblast limited an Analyst Ranking of 71, which means it ranks higher than 71 of stocks, based on data compiled by InvestorsObserver.

Overall Score - 4.7
Wall Street analysts are rating MESO a Strong Buy today. Find out what this means to you and get the rest of the rankings on MESO!

Why are Analyst Ratings Important?

Fundamental research of the underlying health of a company can be an extremely useful resource when making investment decisions. Analysts observe growth prospects and forecasted earnings of companies to gain a comprehensive view of particular industries. This data allows traders to react before numbers are officially reported.

Investors Observer takes the ratings from these analysts and percentile ranks those aveages. This allows you to compare stocks extensively and in more detail than the common buy/hold/sell ratings.

What's Happening With Mesoblast limited Stock Today?

Mesoblast limited (MESO) stock is trading at $19.01 as of 10:22 AM on Monday, Sep 28, a gain of $1.47, or 8.38% from the previous closing price of $17.54. The stock has traded between $18.20 and $19.10 so far today. Volume today is light. So far 243,217 shares have traded compared to average volume of 1,665,521 shares.

Click Here to get the full report on Mesoblast limited (MESO) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App